Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-681-1 | CAS number: 98-56-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin sensitising
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
The aim of this study was to evaluate the skin sensitization potential of 4-chloro-a,a,a-trifluorotoluene (PCBTF) following dermal exposure in the Local Lymph Node Assay, according to the OECD guideline 429. The test item was a liquid hence applicability of the 100 % concentration (the undiluted test item) was evaluated in order to test the highest test concentration possible. Further test concentrations were achieved by formulation of the test item inN,N-Dimethylformamide (DMF). Both the undiluted test item and the formulations were adequately applicable on the ears of animals. Based on results of the preliminary irritation/toxicity test 4-chloro-a,a,a-trifluorotoluene (PCBTF) was examined in the LLNA at concentrations of 100 % as the undiluted test item and as 75 %, 50 % or 25 % (w/v) formulations in DMF according to the relevant guidelines.
28 female CBA/Ca mice were allocated to 7 groups of four animals each:- four groups received4-chloro-a,a,a-trifluorotoluene (PCBTF)at four different concentrations of 100 %, 75 %, 50 % and 25 % (w/v), - the positive control group receiveda-Hexylcinnamaldehyde (HCA) at concentration of 25 % (w/v), - one control group (used as negative control for the groups treated with the test item) received the vehicle of the test item (DMF) only, - one control group (used as negative control for the group treated with the positive control substance) received the vehicle of the positive control (AOO) only. Each substance was applied on the external surface of each ear of the animals for three consecutive days (Day 1, 2 and 3). There was no treatment on Days 4, 5 and 6. On Day 6 animals were intravenously injected via the tail vein with tritiated methyl thymidine (3HTdR), than sacrificed approximately 5 hours after the injection. Auricular lymph nodes were removed and processed. The cell proliferation in the local lymph nodes was measured by incorporation of3HTdR and the obtained values were used to calculate stimulation indices (SI). The positive control item (25 % HCA in AOO) induced the appropriate (SI ³ 3) stimulation over the control (SI value was 11.2), thus confirming the validity of the assay. No mortality was observed during the study. No significant, treatment related effect on body weights or any other signs of systemic toxicity were observed in any treatment group during the test. No signs of significant irritation or any other local effect were observed at the treatment site (ears) in any treatment group. Visually largerlymph nodes than the relevant controls were observed in the positive control group only. Visual appearance of the lymph nodes was normal in the negative control groups (both DMF and AOO) and in the test item treated groups. In spite of normal visual appearance of the lymph nodes significantly increased lymphoproliferation (indicated by an SI ³ 3) compared to the relevant control (DMF) was noted for 4-chloro-a,a,a-trifluorotoluene (PCBTF)at concentrations of 100 %, 75 % and 50 %. No significantly increased lymphoproliferation was observed at test item concentration of 25 %. The stimulation index values were 7.3, 6.9, 8.1 and 1.1 at concentrations of 100 %, 75 %, 50 % and 25 %, respectively. Dose-related response was observed, although its linearity was not statistically significant(p = 0.30, r = 0.70, evaluated by linear regression using SI values).
Since the test was valid and no sign of systemic toxicity or irritation was observed, the proliferation values obtained are considered to reflect the real potential of the test item to cause/not cause lymphoproliferation in the Local Lymph Node Assay. Although
linearity of the observed dose-response proved not to be statistically significant, the increased lymphoproliferation observed at three test concentrations (100 %, 75 % and 50 %) is considered evidence that4-chloro-a,a,a-trifluorotoluene (PCBTF) has sensitization potentialaccording to evaluation criteria of therelevant guidelines.
EC3calculation was conducted by linear interpolation using data points lying immediately above and below the SI value of 3 on the LLNA dose-response curve. The calculated EC3value of 4-chloro-a,a,a-trifluorotoluene (PCBTF) based on the dose-response was 31.8 % in this LLNA. Using the EC3value.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the EC3 value calculated using the dose-response curve (31.8 %), PCBTF was classified as sensitising Sub-category 1B according to the CLP Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.